Allogeneic Transplantation
Non-Cancerous Blood Disorder Trials
COMIRB: 23-1265
A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
Principal Investigator: Gemlyn George
Eligibility: Ages ≥ 18; Recent unfractionated heparin or low-molecular-weight heparin exposure
Request an Appointment
If you would like to schedule an appointment, please give us a call.
Our intake coordinator will help you navigate the process of becoming a new patient including helping you obtain the necessary referrals, get the necessary medical records transferred, and coordinate care with your existing physicians. We are available to answer your questions about our clinic, your treatment, and participation in ongoing clinical trials.